Company Analysis HUTCHMED (China) Limited
1. Summary
Advantages
- The stock's return over the last year (-15.99%) is higher than the sector average (-34.76%).
- Current debt level 6.51% is below 100% and has decreased over 5 years from 7.12%.
- The company's current efficiency (ROE=13.8%) is higher than the sector average (ROE=13.11%)
Disadvantages
- Price (3.82 $) is higher than fair price (1.64 $)
- Dividends (0%) are below the sector average (1.76%).
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| HUTCHMED (China) Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | -0.2% | 0.5% |
| 90 days | -16% | -35.4% | 3.8% |
| 1 year | -16% | -34.8% | 23.4% |
HMDCF vs Sector: HUTCHMED (China) Limited has outperformed the "Healthcare" sector by 18.77% over the past year.
HMDCF vs Market: HUTCHMED (China) Limited has significantly underperformed the market by -39.38% over the past year.
Stable price: HMDCF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: HMDCF with weekly volatility of -0.3075% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (3.82 $) is higher than the fair price (1.64 $).
Price is higher than fair: The current price (3.82 $) is 57.1% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (32.9) is higher than that of the sector as a whole (31.52).
P/E vs Market: The company's P/E (32.9) is lower than that of the market as a whole (46.91).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (4.46) is higher than that of the sector as a whole (3.36).
P/BV vs Market: The company's P/BV (4.46) is higher than that of the market as a whole (-8.98).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (3.95) is higher than that of the sector as a whole (3.24).
P/S vs Market: The company's P/S indicator (3.95) is lower than that of the market as a whole (4.88).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (121.88) is higher than that of the sector as a whole (9.95).
EV/Ebitda vs Market: The company's EV/Ebitda (121.88) is higher than that of the market as a whole (25.28).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -36.04% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-36.04%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-52.93%).
5.4. ROE
ROE vs Sector: The company's ROE (13.8%) is higher than that of the sector as a whole (13.11%).
ROE vs Market: The company's ROE (13.8%) is higher than that of the market as a whole (-8.23%).
5.5. ROA
ROA vs Sector: The company's ROA (7.88%) is higher than that of the sector as a whole (6.14%).
ROA vs Market: The company's ROA (7.88%) is higher than that of the market as a whole (4.85%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.56%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11.03%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.76%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (1.5E-5%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
